跳转至内容
Merck

793558

Sigma-Aldrich

碘化钠

anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%

登录查看公司和协议定价


About This Item

线性分子式:
NaI
CAS号:
分子量:
149.89
EC號碼:
MDL號碼:
分類程式碼代碼:
12352300
PubChem物質ID:
NACRES:
NA.21

等級

anhydrous

品質等級

蒸汽密度

>1 (vs air)

產品線

ReagentPlus®
Redi-Dri

化驗

≥99%

形狀

powder

品質

free-flowing

雜質

≤1.0% water

pH值

6-9 (20 °C, 50 g/L)

mp

661 °C (lit.)

SMILES 字串

[Na+].[I-]

InChI

1S/HI.Na/h1H;/q;+1/p-1

InChI 密鑰

FVAUCKIRQBBSSJ-UHFFFAOYSA-M

正在寻找类似产品? 访问 产品对比指南

一般說明

碘化钠是一种无机钠盐。在有机合成中可用作碘化剂,制备各种含碘化合物。可用于通过亲核取代反应将卤代烃和磺酸酯转换为烷基碘化物和芳基碘化物。此外,碘化钠还可联合氧化剂碘化有机硼烷、酚和芳基化合物。

應用

碘化钠可用作碘盐前体,通过缓慢蒸发溶剂法合成双硫脲碘化钠(bis thiourea sodium iodide)的半有机非线性光学单晶。

法律資訊

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC

訊號詞

Danger

危險分類

Aquatic Acute 1 - Eye Irrit. 2 - Skin Irrit. 2 - STOT RE 1 Oral

標靶器官

Thyroid

儲存類別代碼

6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

P E N Braad et al.
Physics in medicine and biology, 60(13), 5297-5312 (2015-06-26)
Peri-therapeutic (124)I-PET/CT is of interest as guidance for radioiodine therapy. Unfortunately, image quality is complicated by dead time effects and increased random coincidence rates from high (131)I-activities. A series of phantom experiments with clinically relevant (124)I/(131)I-activities were performed on a
Kohei Sano et al.
Biochemical and biophysical research communications, 464(3), 820-825 (2015-07-15)
Photoacoustic (PA) imaging is an attractive imaging modality for sensitive and depth imaging of biomolecules with high resolution in vivo. The aim of this study was to evaluate the effectiveness of an anti-epidermal growth factor receptor (EGFR) monoclonal antibody (panitumumab; Pan)
Mohamed Touati et al.
Leukemia & lymphoma, 56(2), 332-341 (2014-04-29)
Finding new prognostic factors to identify patients with Hodgkin lymphoma (HL) at risk of treatment resistance or relapse remains challenging in daily practice. We evaluated the relationship between CD68 expression, interim positron emission tomography (iPET) results and outcome in 158
Anke de Vries et al.
Investigative radiology, 50(4), 297-304 (2015-01-01)
The objective of this study was to investigate the feasibility and the accuracy of spectral computed tomography (spectral CT) to determine the tissue concentrations and localization of high-attenuation, iodine-based contrast agents in mice. Iodine tissue concentrations determined with spectral CT
Marlein Miranda Cona et al.
International journal of oncology, 44(3), 819-829 (2013-12-25)
Iodine-131‑labeled monoiodohypericin (131I‑Hyp) is a necrosis avid compound used as a complementary anticancer agent. Herein, the biodistribution in rats with re-perfused partial liver infarction (RPLI) was used to estimate its human internal radiation dosimetry. Iodine-123‑labeled monoiodohypericin (123I-Hyp) as a safer

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门